Abstract-Adriamycin, an anticancer drug, caused dramatic increases in the serum lipid levels of rats fed a high-cholesterol diet. Male Lewis inbred rats were fed a basal or 1.5% cholesterol diet containing 0.5% cholic acid for 8 weeks.
A direct correlation between lipid peroxide contents in the aortic wall and the severity of atherosclerotic lesions was first demonstrated in 1952 (1 ) . Recent reports have emphasized that lipid peroxide is an important risk factor in the development of atherosclerosis (2-6). Lipid peroxides are also known to powerfully inhibit the formation of prostacyclin, which protects the arterial wall against platelet deposition (7, 8) . Gryglewski (9) hypo thesized that atherosclerosis is a disease due to prostacyclin deficiency, which is caused by intoxication of prostacyclin syn thetase with lipid peroxides or the cor responding free radicals.
Adriamycin, an anthracycline antibiotic, is one of the most important drugs in cancer chemotherapy.
However, it initiates free radical-mediated chain reactions which result in conversion of the membrane unsaturated fatty acids to lipid peroxides and cause membrane damage (110-13). Thus, adriamycin may cause injury to the arterial wall with increased lipid peroxidation.
The purpose of the present study is to investigate the effect of adriamycin on lipid levels in the serum and aorta of rats fed a high cholesterol diet. Some of the results were reported to the Pharmacological Society in Japan (14).
Materials and Methods

Animals and treatments:
Five-week-old male Wistar Lewis LEW/Crj rats (Charles River Japan) were housed in an air conditioned room (23±2'C and 60+10% humidity) and maintained on a purified basal diet or a high-cholesterol diet. The basal diet contained 20% casein, 63.2% sucrose, 10% corn oil, 2% agar, 0.8% vitamin mixture and 4% salt mixture (15). The high-cholesterol diet consisted of the basal diet supplemented with 1.5% cholesterol and 0.5% cholic acid in place of an equal amount of sucrose. Animals were divided into five groups (Table 1) . Groups I and III were fed the basal diet. Groups II, IV and V were fed the high cholesterol diet. Adriamycin (Kyowa Hakko Kogyo) was administered twice a week at doses of 1.5 mg/kg body weight (s.c. and i.p., alternately) to the rats in Groups III and IV. The injection method was altered to minimize the topical irritation of adriamycin. In Group V, a large dose of adriamycin (6.0 mg/kg body weight, s.c.) was injected every other week. Group I and I I were injected with saline alone.
Each animal was given 15 g of the respective diet every day and all food not consumed after 24 hr was discarded. The rats were weighed weekly during the experiment.
Lipid analysis: After overnight fasting, blood was drawn from the tail vein at weekly intervals for serum cholesterol determination and at biweekly intervals for the determination of triglycerides, phospholipid and lipid peroxides.
Serum was separated by cen trifugation (1500xg for 10 min) and stored at -20°C until analysis.
At the end of the experimental period (8 weeks), the rats, after overnight fasting, were sacrificed under ether anesthesia by bleeding from a cannula inserted into the abdominal aorta close to the iliac bifurcation. Then the aorta and liver were excised. The aorta was freeze-dried to a constant weight and cut into small segments, and lipids were subsequently extracted at 50°C for 20 min with chloroform-methanol Lipid peroxide level in serum: As shown in Fig. 2 , the serum levels of lipid peroxides gradually increased in adriamycin-treated groups. At the end of the experimental period, the lipid peroxide levels for Groups III, IV and V were 3.9, 2.4 and 3.9 higher, respec tively, than their respective dietary control group (Groups I and II) (Fig. 2) . However, the animals fed the high-cholesterol diet (Groups II and IV) showed significant reduction in lipid peroxide level in comparison with the corresponding control group (Groups I and III).
Lipid levels in serum: The time courses of serum cholesterol, triglyceride and phos pholipid levels are given in Fig. 3 and Table 2 . The high-cholesterol diet resulted in im mediate increases in serum total cholesterol levels, while treatment with a small dose of adriamycin produced gradual increases (Fig.  3) . However, Group V animals, which were treated with a large dose of adriamycin biweekly, showed an outstanding increase in serum total cholesterol levels from the 3rd week with a sustained high level (approx. 2000 mg/100 ml) from the 6th week to necropsy. The cholesterol level of Group IV animals rapidly elevated after 7 weeks, reaching the same levels as that of the Group V animals. The cholesterol level in Group III treated with adriamycin alone became sig nificantly higher at the end of the experiment than that in Group II supplemented with a high-cholesterol diet. Serum free cholesterol and cholesterol ester levels changed in parallel with that of total cholesterol throughout the experimental period (Table 2) .
Serum triglyceride levels in the cholesterol fed groups (Groups II and IV) were much lower than in the corresponding control groups. Adriamycin treatment had no effect on the serum triglyceride levels during the first half of the experimental period, but caused a marked increase in the latter half. In Group V, serum triglycerides rose to over ml at 6 weeks after drug treatment.
Serum phospholipid levels were also strikingly increased by cholesterol feeding and adriamycin treatment in parallel with the serum cholesterol levels (Table 2) . Lipid levels in aorta and liver: As shown in Table 3 , slight but significant increases (5 10%) in total cholesterol levels of the aorta were observed in all of the high-cholesterol diet-fed groups (Groups II, IV and V) com pared to the control group (Group I), but there was no significant difference among the high-cholesterol diet-fed groups. Aortic cholesterol ester levels in Groups IV and V were significantly higher than those in the control groups (Groups I and II). Triglyceride levels of the aorta in Group V were sig nificantly lower than those in Groups I and II.
Both liver cholesterol and triglyceride levels were markedly increased by feeding with cholesterol, while the latter lipids were significantly decreased by treatment with adriamycin.
Serum protein levels and enzyme activities: Animals fed the high-cholesterol diet (Group II) showed significant increase in both serum total protein and albumin levels to almost the same extent when com pared to the control group (Group I) (Table  4) . Consequently, there was no difference in the A/G ratio between Groups I and II. On the other hand, adriamycin-treated groups (Groups III, IV and V) showed remarkable reductions in both levels of total protein and albumin when compared to the control groups (Groups I and II). The A/G ratio was also markedly decreased, since the reduction in albumin levels was much greater than that in globulin levels.
Significant increases in serum ALP, GOT and GPT activities were observed in Group II animals. Adriamycin-treated groups showed significant reductions in ALP activity, sig nificant increases in GPT activity and no difference in GOT activity compared to their respective dietary control group (Table 4) . 
Discussion
The results presented in this study indicate that the concentrations of all serum lipids in rats increase markedly upon prolonged treatment with adriamycin and a high cholesterol diet.
Adriamycin facilitates the generation of oxygen radicals (21, 22), which stimulate lipid peroxidation, and elevates lipid peroxide levels in serum (23, 24) and tissues (10, 24, 25) of mice or guinea pigs. As could be expected, serum lipid peroxide levels in rats treated with adriamycin markedly increased in our study. Interestingly, the high cholesterol diet had a lowering effect on serum lipid peroxide levels, not only in control animals but also in the adriamycin-treated animals, except for Group V which received large doses of the drug. That diet also lowered the serum triglyceride levels. We do not yet know why the serum lipid peroxide level is low in animals fed a high-cholesterol diet and whether this change reflects lowering of the serum triglyceride level.
Adriamycin treatment or high-cholesterol diet had a moderate elevating effect on serum lipid levels. However, their combination produced dramatic elevation of free and total cholesterol and phospholipid levels, even triglyceride levels in Group V ( Table  2 ), indicating that the severe hyperlipidemia results from synergism between adriamycin treatment and cholesterol feeding.
Adriamycin is known to have a number of detrimental effects, which include myelo suppression, damage to gastrointestinal mucosa, and cumulative and dose-dependent cardiotoxicity (26), which is presumably associated with lipid peroxidation (10). Also, toxic injuries to the liver (27, 28) and kidney (29) have been recorded in animals and humans treated with adriamycin. Our study indicates that the development of hyper lipidemia might parallel the induction of adriamycin toxicity. Hyperlipidemia may result from its hepatotoxicity or nephro toxicity. Although secondary hyperlipidemia in relation to liver disease is known in alcoholism and cholestasis, serum lipid levels usually decrease or are lower than normal in liver disease with parenchymal injury. In our study, the ester ratio (the ratio of cholesterol ester to total cholesterol) was almost constant in animals treated with adriamycin ( Table 2 ). The cholesterol ester in serum is synthesized by lecithin-cholesterol acyltransferase (LCAT) (30). Since LCAT is secreted from the liver, the ester ratio in serum is considered to be a sign of liver function on lipid metabolism. Therefore, our results indicate that the liver function was not severely impaired by adriamycin treatment. Furthermore, in rats treated with adriamycin, serum ALP, GOT and GPT activities as indexes of liver disease were only slightly different from their respective control values (Table 4) , sup porting the view mentioned above.
The nephrotic syndrome is characterized by proteinuria, hypoalbuminemia, hyperlipidemia and edema. These features were observed in the present experiment.
Our results agree with the observation of Bertani et al. (31 ) and Bizzi et al. (32) , who reported that adriamycin produces hyperlipidemia as a consequence of its nephrotoxicity. We therefore concluded that the hyperlipidemia observed in this study basically results from adriamycin-induced nephrosis and can be extremely enhanced by combination with a high-cholesterol diet. The mechanisms of nephrosis-hyperlipidemia are not sufficiently understood but are thought to be related to increased hepatic lipoprotein synthesis and secretion (33), reduction of lipid storage and utilization (32), and lack of lipoprotein lipase activation (34).
Generally, both hyperlipidemia and a high level of lipid peroxide are considered to increase the risk for the induction and development of atherosclerosis. In spite of the strikingly high levels of serum lipids and lipid peroxides in this study, cholesterol accumulation in the aorta was only slight, and the aorta triglyceride levels were even rather reduced (Table 3) . This further supports the idea that the rat is very resistant to the induction of atherosclerosis, at least that due to hyperlipidemia.
